Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 238

1.

IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto's thyroiditis.

Stanciu AE, Serdarevic N, Hurduc AE, Stanciu MM.

Scand J Clin Lab Invest. 2015 Nov;75(7):539-48. doi: 10.3109/00365513.2015.1057895. Epub 2015 Jul 25.

PMID:
26305420
2.

Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.

Latrofa F, Ricci D, Montanelli L, Rocchi R, Piaggi P, Sisti E, Grasso L, Basolo F, Ugolini C, Pinchera A, Vitti P.

J Clin Endocrinol Metab. 2012 Jul;97(7):2380-7. doi: 10.1210/jc.2011-2812. Epub 2012 Apr 26.

PMID:
22539585
3.

Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis.

Lun Y, Wu X, Xia Q, Han Y, Zhang X, Liu Z, Wang F, Duan Z, Xin S, Zhang J.

Otolaryngol Head Neck Surg. 2013 Mar;148(3):396-402. doi: 10.1177/0194599812472426. Epub 2013 Jan 8.

PMID:
23300224
4.

Hashimoto's thyroiditis and papillary thyroid carcinoma. Are cytokeratin 19 and P63 proteins of any diagnostic value?

Divani SN, Kalodimos GP, Lioupis MA, Syrmos NC.

Hell J Nucl Med. 2016 Sep-Dec;19(3):250-253. doi: 10.1967/s002449910408. Epub 2016 Nov 8.

5.

High TPOAb Levels (>1300 IU/mL) Indicate Multifocal PTC in Hashimoto's Thyroiditis Patients and Support Total Thyroidectomy.

Dong S, Xia Q, Wu YJ.

Otolaryngol Head Neck Surg. 2015 Jul;153(1):20-6. doi: 10.1177/0194599815581831. Epub 2015 Apr 27.

PMID:
25917667
6.

Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients.

Liang J, Zeng W, Fang F, Yu T, Zhao Y, Fan X, Guo N, Gao X.

Acta Otorhinolaryngol Ital. 2017 Oct;37(5):393-400. doi: 10.14639/0392-100X-1709.

7.

Well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence.

Huang BY, Hseuh C, Chao TC, Lin KJ, Lin JD.

Endocr Pathol. 2011 Sep;22(3):144-9. doi: 10.1007/s12022-011-9164-9.

PMID:
21647844
9.

The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease.

Zhang L, Li H, Ji QH, Zhu YX, Wang ZY, Wang Y, Huang CP, Shen Q, Li DS, Wu Y.

BMC Cancer. 2012 Dec 21;12:610. doi: 10.1186/1471-2407-12-610.

10.

Clinical Relationship Between IgG4-Positive Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma.

Yu Y, Zhang J, Lu G, Li T, Zhang Y, Yu N, Gao Y, Gao Y, Guo X.

J Clin Endocrinol Metab. 2016 Apr;101(4):1516-24. doi: 10.1210/jc.2015-3783. Epub 2016 Feb 11.

PMID:
26866571
11.

Osteopontin levels in patients with papillary thyroid cancer according to the presence of Hashimoto's thyroiditis.

Park SH, Park CS, Kim YI, Nam-Goong IS, Kim YS, Lee JC, Choi JI, Park JW, Kim ES.

Asian Pac J Cancer Prev. 2015;16(6):2447-51.

12.

[Assessment of 25(OH)D3, concentration levels in patients with papillary thyroid cancer compared to patients with Hashimoto's thyroiditis].

Lizis-Kolus K, Hubalewska-Dydejczyk A, Trofimiuk-Muldnerz M, Sowa-Staszczak A, Kowalska A.

Przegl Lek. 2013;70(11):920-5. Polish.

PMID:
24697030
13.

Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies.

Latrofa F, Ricci D, Grasso L, Vitti P, Masserini L, Basolo F, Ugolini C, Mascia G, Lucacchini A, Pinchera A.

J Clin Endocrinol Metab. 2008 Feb;93(2):591-6. Epub 2007 Nov 20.

PMID:
18029466
14.

Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.

Vasileiadis I, Boutzios G, Charitoudis G, Koukoulioti E, Karatzas T.

Ann Surg Oncol. 2014 Aug;21(8):2725-32. doi: 10.1245/s10434-014-3593-x. Epub 2014 Mar 5.

PMID:
24595799
15.

The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma.

Zhang Y, Dai J, Wu T, Yang N, Yin Z.

J Cancer Res Clin Oncol. 2014 Jun;140(6):1021-6. doi: 10.1007/s00432-014-1629-z. Epub 2014 Mar 12.

PMID:
24619663
16.

Influence of chronic autoimmune thyroiditis and papillary thyroid cancer on serum calcitonin levels.

Rosario PW, Calsolari MR.

Thyroid. 2013 Jun;23(6):671-4. doi: 10.1089/thy.2012.0564. Epub 2013 May 28.

PMID:
23327335
17.

Influence of coexistent Hashimoto's thyroiditis on the extent of cervical lymph node dissection and prognosis in papillary thyroid carcinoma.

Song E, Jeon MJ, Park S, Kim M, Oh HS, Song DE, Kim WG, Kim WB, Shong YK, Kim TY.

Clin Endocrinol (Oxf). 2018 Jan;88(1):123-128. doi: 10.1111/cen.13475. Epub 2017 Oct 4.

PMID:
28906015
18.

Hashimoto's Thyroiditis Does Not Affect Ultrasonographical, Cytological, and Histopathological Features in Patients with Papillary Thyroid Carcinoma.

Baser H, Ozdemir D, Cuhaci N, Aydin C, Ersoy R, Kilicarslan A, Cakir B.

Endocr Pathol. 2015 Dec;26(4):356-64. doi: 10.1007/s12022-015-9401-8.

PMID:
26481630
19.
20.

Supplemental Content

Support Center